Ranked #548 of 8,699 institutional investors
Avoro Capital Advisors LLC
New York, NY
$8.75B
US stock portfolio at live prices · today −$78.8M (−0.89%)
Live prices, last trade 11:41 AM ET
- Value at quarter end (Q3 2026)
- $9.69B
- Change from Q2 2026
- −$1.45B (−12.98%)
- Positions
- 25 · 3 new, 0 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$1.47B of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesUTHR 17.5%ARGX 10.7%KRYS 10.4%KYMR 9.93%MDGL 8.18%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| UTHR United Therapeutics Corporation | 2,755,555 | $1.53B | 17.5% | Reduced −1% |
| ARGX argenx SE | 1,000,000 | $938M | 10.7% | Unchanged |
| KRYS Krystal Biotech, Inc. | 2,888,888 | $908M | 10.4% | Unchanged |
| KYMR Kymera Therapeutics, Inc. | 7,474,747 | $869M | 9.93% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 1,833,333 | $716M | 8.18% | Unchanged |
| ARWR Arrowhead Pharmaceuticals, Inc. | 11,000,000 | $472M | 5.39% | Reduced −3% |
| RVMD Revolution Medicines, Inc. | 2,145,000 | $350M | 4.00% | Reduced −7% |
| CYTK Cytokinetics, Incorporated | 4,900,000 | $254M | 2.91% | Reduced −2% |
| XENE Xenon Pharmaceuticals Inc. | 5,500,000 | $205M | 2.35% | Reduced −5% |
| DFTX Definium Therapeutics, Inc. | 7,050,000 | $205M | 2.35% | Reduced −2% |
| VERA Vera Therapeutics, Inc. | 5,635,000 | $145M | 1.66% | Reduced −2% |
| GPCR Structure Therapeutics Inc. | 6,555,555 | $108M | 1.23% | Unchanged |
| TSHA Taysha Gene Therapies, Inc. | 23,888,888 | $89.1M | 1.02% | Unchanged |
| CELC Celcuity Inc. | 1,500,000 | $82.2M | 0.94% | Reduced −56% |
| VRDN Viridian Therapeutics, Inc. | 2,500,000 | $76.9M | 0.88% | Unchanged |
| COAG Hemab Therapeutics Holdings, Inc. | 1,892,372 | $74.9M | 0.86% | Reduced −2% |
| OCUL Ocular Therapeutix, Inc. | 12,380,300 | $70.8M | 0.81% | Reduced −1% |
| SEPN Septerna, Inc. | 1,300,000 | $50.9M | 0.58% | Reduced −3% |
| ABVX ABIVAX Société Anonyme | 488,000 | $34.1M | 0.39% | New |
| SCTX Scribe Therapeutics Inc. | 2,598,973 | $31.5M | 0.36% | New |
| BRVE Braveheart Bio, Inc. | 1,255,000 | $25.0M | 0.29% | New |
| AVTX Avalo Therapeutics, Inc. | 2,377,777 | $16.1M | 0.18% | Added +2% |
| FTH Faeth Therapeutics, Inc. | 1,410,000 | $12.2M | 0.14% | Reduced −2% |
| WHWK Whitehawk Therapeutics, Inc. | 2,849,402 | $8.7M | <0.1% | Unchanged |
| LXEO Lexeo Therapeutics, Inc. | 525,000 | $1.7M | <0.1% | Reduced −65% |